EFFECT OF LOW MEASLES ANTIBODY TITER ON INFANT IMMUNITY

NIH RePORTER · NIH · R01 · $145,446 · view on reporter.nih.gov ↗

Abstract

The objective is to improve the effectiveness of measles and tetanus vaccines in developing countries, thereby diminishing mortality and debility there, reducing measles virus importation to the USA and learning more about the identity of the immunoglobulin which protect against measles and the factors which control their transport to the fetus. Specifically we will: 1. Identify the factors(s) which determine the age at which a child becomes susceptible to measles and responsive to vaccine. 2. Study the relative roles in protection from disease of immunologlobulin idiotypes directed toward the four major structural proteins of measles virus. 3. Quantitate the response of the human adult to repeated doses of tetanus toxiod and to set up practical guidelines for determination of vaccine needs in diverse populations. 4. Seek to learn more about the mechanism of transplacental movement of immunoglobulins in humans.

Key facts

NIH application ID
3127997
Project number
5R01AI018502-06
Recipient
YALE UNIVERSITY
SAM.gov UEI
FL6GV84CKN57
Principal Investigator
FRANCIS L BLACK
Activity code
R01
Funding institute
NIH
Fiscal year
1987
Award amount
$145,446
Award type
5
Project period
1982-04-01 → 1988-03-31